Influence of salinity and fish species on PAH uptake from dispersed crude oil

Mar Pollut Bull. 2006 Oct;52(10):1182-9. doi: 10.1016/j.marpolbul.2006.02.009. Epub 2006 Mar 6.

Abstract

The use of chemical oil dispersants to minimize spill impacts causes a transient increase in hydrocarbon concentrations in water, which increases the risk to aquatic species if toxic components become more bioavailable. The risk of effects depends on the extent to which dispersants enhance the exposure to toxic components, such as polycyclic aromatic hydrocarbons (PAH). Increased salinities can reduce the solubility of PAH and the efficiency of oil dispersants. This study measured changes in the induction of CYP1A enzymes of fish to demonstrate the effect of salinity on PAH availability. Freshwater rainbow trout and euryhaline mummichog were exposed to water accommodated fractions (WAF), and chemically-enhanced water accommodated fractions (CEWAF) at 0 per thousand, 15 per thousand, and 30 per thousand salinity. For both species, PAH exposure decreased as salinity increased whereas dispersant effectiveness decreased only at the highest salinity. Hence, risks to fish of PAH from dispersed oil will be greatest in coastal waters where salinities are low.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Assay / methods
  • Cytochrome P-450 CYP1A1 / analysis
  • Cytochrome P-450 Enzyme System / analysis
  • Cytochrome P-450 Enzyme System / biosynthesis
  • Cytochrome P-450 Enzyme System / drug effects*
  • Fresh Water
  • Fundulidae / metabolism*
  • Lipids
  • Oncorhynchus mykiss / metabolism*
  • Petroleum / toxicity*
  • Polycyclic Aromatic Hydrocarbons / analysis
  • Polycyclic Aromatic Hydrocarbons / pharmacokinetics*
  • Salinity
  • Seawater / chemistry
  • Sodium Chloride / analysis
  • Solubility

Substances

  • Lipids
  • Petroleum
  • Polycyclic Aromatic Hydrocarbons
  • corexit 9500
  • Sodium Chloride
  • Cytochrome P-450 Enzyme System
  • Cytochrome P-450 CYP1A1